Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma ...

Atria Investments Inc boosted its holdings in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 54.0% during ...

Proficio Capital Partners LLC bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) during ...

This was the stock's second consecutive day of losses.

Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

Zimmer Biomet CEO Ivan Tornos said he anticipates ASCs to be a major support for growing orthopedic case volumes during the Barclays 27th Annual Global Healthcare Conference. “That is a huge tailwind ...

Zimmer Biomet aims for 4% to 5% growth in orthopedics, driven by demographic trends and technological advancements. The company plans to regain market share in the hip category with new product ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).

Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings. Such statements are based upon ...

Schwarzenegger joined Zimmer as chief movement officer in November 2024 to promote joint health to wide-ranging communities in the US. The new campaign, called “You’ll Be Back”, is a play on a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.